Blue Trust’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Blue Trust's NVS Position: Q3 2026 in Review
Blue Trust reduced its Novartis (NVS) stake by 28% in Q3 2026, selling an estimated $419K and leaving 6,938 shares worth $989K. The position accounts for 0.01% of the portfolio, ranked #300.
Blue Trust first reported a position in NVS in Q2 2022 and has held it in 18 quarters since. The position peaked at $1.52M in Q1 2026. 1,370 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Blue Trust held 6,938 shares of Novartis worth $989K as of Q3 2026.
- Blue Trust sold 2,762 Novartis shares in Q3 2026, an estimated $419K.
- Novartis made up 0.01% of Blue Trust's portfolio in Q3 2026, its #300 holding.
- Blue Trust first reported a position in Novartis in Q2 2022 and has held it in 18 quarters since.
- Blue Trust's Novartis position peaked at $1.52M in Q1 2026.
- 1,370 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.